Abstract
Exposure to household air pollution is a leading cause of ill-health globally. The Household Air Pollution Intervention Network (HAPIN) randomized controlled trial evaluated the impact of a free liquefied petroleum gas stove and fuel intervention on birth outcomes and maternal and child health. As part of HAPIN, an extensive exposure assessment was conducted. Here, we report on PM2.5 and CO exposures of young children (≤ 15 months old) reconstructed using a Bluetooth-beacon based time-activity monitoring system coupled with microenvironmental pollutant monitors. Median (IQR) exposures to PM2.5 were 65.1 (33 – 128.2) µg/m3 in the control group and 22.9 (17.2 – 35.3) µg/m3 in the intervention group; for CO, median (IQR) exposures were 1.1 (0.3 – 2.9) ppm and 0.2 (0 – 0.7) ppm for control and intervention group, respectively. Exposure reductions were stable over time and consistent with previous findings for the children’s mothers. In the intervention group, 75% of children’s reconstructed exposures were below the WHO interim target guideline value of 35 µg/m3, while 26% were below the standard in the control group. Our findings suggest that an LPG fuel and stove intervention can substantially reduce children’s exposure to household air pollution.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT02944682
Funding Statement
This study was funded by the U.S. National Institutes of Health (NIH; cooperative agreement 1UM1HL134590) in collaboration with the Bill & Melinda Gates Foundation (OPP1131279).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol has been reviewed and approved by institutional review boards (IRBs) and Ethics Committees at Emory University (00089799), Johns Hopkins University (00007403), Sri Ramachandra Institute of Higher Education and Research (IEC-N1/16/JUL/54/49), the Indian Council of Medical Research - Health Ministry Screening Committee (5/8/4-30/(Env)/Indo-US/2016-NCD-I), Universidad del Valle de Guatemala (146-08-2016), Guatemalan Ministry of Health National Ethics Committee (11-2016), Asociacion Benefica PRISMA (CE2981.17), the London School of Hygiene and Tropical Medicine (11664-5), the Rwandan National Ethics Committee (No.357/RNEC/2018), and Washington University in St. Louis (201611159). The study has been registered with ClinicalTrials.gov (Identifier NCT02944682).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
